Topics

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volumes

2019-07-10 14:02:25 | BioPortfolio

Summary

To evaluate long-term safety of YVOIRE volumes by incidence of adverse events including injection site local reactions and biodegradability.

Study Design

Time Perspective: Prospective

Conditions

Healthy Adults With Extreme, Severe, Moderate, or Light Nasolabial Folds

Intervention

YVOIRE volumes

Status

Active, not recruiting

Source

LG Life Sciences

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-07-10T14:02:25-0400

Clinical Trials [3349 Associated Clinical Trials listed on BioPortfolio]

A Study of YVOIRE Y-Solution 360 for Hand Augmentation to Correct Volume Loss

The purpose of this study is to evaluate the effectiveness and safety of YVOIRE Y-Solution 360 in the treatment of dorsal hand to correct volume loss.

Open Label Continuation Study in Moderate to Severe Psoriasis

Long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis

Neuramis® Deep Lidocaine Compared to YVOIRE® Volume Plus for Correction of Nasolabial Folds

This clinical investigation is a randomized, evaluator-blind, active controlled, noninferiority study to evaluate the effectiveness and safety of Neuramis® Deep Lidocaine when compared wi...

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

This is a multiple dose escalating and open labeled clinical trial to evaluate the safety, tolerability, and pharmacokinetics (PK) of multiple subcutaneous (s.c.) injections of SHR-1314 in...

L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults

Randomized, double blind, controlled clinical trial, to evaluate safety and efficacy of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475 as adjuvant to reduce the severity of symptoms in ...

PubMed Articles [16322 Associated PubMed Articles listed on BioPortfolio]

Trends In Opioid Prescribing And Self-Reported Pain Among US Adults.

Clinically informed efforts to curb inappropriate opioid prescribing seek to reduce prescribing to adults with lower pain levels that are potentially manageable with alternative therapies. According t...

The association of pain interference and opioid use with healthcare utilization and costs, and wage loss among adults with osteoarthritis in the United States.

To examine associations of opioid use and pain interference with activities (PIA), healthcare resource utilization (HRU) and costs, and wage loss in noninstitutionalized adults with osteoarthritis in ...

Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials.

Dupilumab, a human monoclonal antibody, blocks the shared receptor unit for interleukin-4 and interleukin-13. International phase II and III studies have evaluated the efficacy and safety of dupilumab...

Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis.

Crisaborole ointment, 2%, is a non-steroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis (AD). This parallel-cohort, phase 1 study was conducted to investigat...

Disparities in Access to Health Care Among US-Born and Foreign-Born US Adults by Mental Health Status, 2013-2016.

To compare access to care between US-born and foreign-born US adults by mental health status. We analyzed data on nonelderly adults (n = 100 428) from the 2013-2016 National Health Interview Su...

Medical and Biotech [MESH] Definitions

A narcotic antagonist with analgesic properties. It is used for the control of moderate to severe pain.

Respiratory support system used primarily with rates of about 100 to 200/min with volumes of from about one to three times predicted anatomic dead space. Used to treat respiratory failure and maintain ventilation under severe circumstances.

An opioid analgesic used similarly to MORPHINE in the control of moderate to severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1097)

For-profit enterprise with relatively few to moderate number of employees and low to moderate volume of sales.

Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.

More From BioPortfolio on "Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volumes"

Quick Search

Searches Linking to this Trial